Marta Schirripa

FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer

Fotios Loupakis, Chiara Cremolini, Lisa Salvatore et al. · European Journal of Cancer · 2013 · 185 citations

Medicine, Oncology, Pharmacotherapy +10

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection

Marta Schirripa, Francesca Bergamo, Chiara Cremolini et al. · British Journal of Cancer · 2015 · 171 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial

Gianluca Masi, Lisa Salvatore, Luca Boni et al. · Annals of Oncology · 2015 · 169 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Role of<i>NRAS</i>mutations as prognostic and predictive markers in metastatic colorectal cancer

Marta Schirripa, Chiara Cremolini, Fotios Loupakis et al. · International Journal of Cancer · 2014 · 160 citations

Medicine, Oncology, Pathology +16

Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO

Emanuela Dell’Aquila, Chiara Cremolini, Tea Zeppola et al. · Annals of Oncology · 2018 · 134 citations · Full text

Medicine, Immunology, Oncology +17